Aveanna Healthcare (NASDAQ:AVAH) CEO Sells $233,486.44 in Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) CEO Jeff Shaner sold 27,929 shares of the firm’s stock in a transaction on Tuesday, December 30th. The stock was sold at an average price of $8.36, for a total value of $233,486.44. Following the completion of the transaction, the chief executive officer directly owned 2,451,210 shares in the company, valued at approximately $20,492,115.60. This represents a 1.13% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.

Jeff Shaner also recently made the following trade(s):

• On Friday, January 2nd, Jeff Shaner sold 29,357 shares of Aveanna Healthcare stock. The shares were sold at an average price of $7.85, for a total value of $230,452.45.
• On Wednesday, December 31st, Jeff Shaner sold 27,674 shares of Aveanna Healthcare stock. The stock was sold at an average price of $8.18, for a total value of $226,373.32.

Aveanna Healthcare Stock Performance

Shares of NASDAQ AVAH traded down $0.09 during trading on Friday, hitting $8.08. The company had a trading volume of 2,526,966 shares, compared to its average volume of 1,076,101. Aveanna Healthcare Holdings Inc. has a 12 month low of $3.67 and a 12 month high of $10.32. The company has a debt-to-equity ratio of 140.39, a quick ratio of 1.23 and a current ratio of 1.23. The firm has a market capitalization of $1.69 billion, a P/E ratio of 22.44 and a beta of 2.06. The stock has a 50 day simple moving average of $8.92 and a 200 day simple moving average of $7.49.

Aveanna Healthcare (NASDAQ:AVAH) last released its earnings results on Monday, May 22nd. The company reported $0.04 earnings per share (EPS) for the quarter. Aveanna Healthcare had a net margin of 3.29% and a negative return on equity of 143.55%. The company had revenue of $450.53 million during the quarter. As a group, analysts anticipate that Aveanna Healthcare Holdings Inc. will post -0.06 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. Banque Transatlantique SA bought a new stake in Aveanna Healthcare in the first quarter worth $25,000. Quantbot Technologies LP purchased a new position in shares of Aveanna Healthcare in the 2nd quarter worth $43,000. Diversified Trust Co bought a new stake in shares of Aveanna Healthcare in the 2nd quarter worth about $57,000. Jump Financial LLC bought a new stake in shares of Aveanna Healthcare in the 1st quarter worth about $59,000. Finally, MQS Management LLC purchased a new stake in shares of Aveanna Healthcare during the 2nd quarter valued at about $59,000. 87.96% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the stock. JPMorgan Chase & Co. upgraded shares of Aveanna Healthcare from an “underweight” rating to a “neutral” rating and lifted their target price for the company from $6.00 to $10.00 in a research note on Thursday, September 18th. Royal Bank Of Canada raised their price target on Aveanna Healthcare from $8.00 to $10.00 and gave the company a “sector perform” rating in a report on Friday, October 24th. Truist Financial upped their price objective on Aveanna Healthcare from $9.50 to $10.00 and gave the stock a “hold” rating in a research note on Friday, November 7th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Aveanna Healthcare in a research report on Monday. Finally, Zacks Research downgraded Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 20th. Five investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $10.69.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.